These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University].
    Author: Krommer K.
    Journal: Orv Hetil; 1992 May 10; 133(19):1151-8. PubMed ID: 1584596.
    Abstract:
    Treatment protocols for advanced ovarian tumors (stages III-IV), applied at the author's institute, are presented. Giving a short survey the outcome with single agent cyclophosphamide therapy (C; n = 82), combinations without cisplatin (CMV, CAV; n = 83) or combination with cisplatin (CAP; n = 41) has been compared. A significant difference between C and CMV/CAV groups could be found only in regards with remission period (p = 0.0004 and 0.0001). By the use of CAP the result became better not only in the extent and the duration of remission but in the survival as well as compared to that of the other groups. The importance of the extent of residual tumor is emphasized. Because of serious side effects of particularly cisplatin based, three drug combinations the use of combinations consisting of two drugs only can be recommended in accordance with literary data. By the estimation of the usefulness of second look operation's findings the radiotherapy with its consolidationary effect and also the significance of a maintaining or a second line cytostatic treatment are pointed out.
    [Abstract] [Full Text] [Related] [New Search]